Cargando…
Current and Emerging Prognostic Biomarkers in Endometrial Cancer
Endometrial cancer is the most common gynaecological malignancy in high income countries and its incidence is rising. Whilst most women with endometrial cancer are diagnosed with highly curable disease and have good outcomes, a significant minority present with adverse clinico-pathological character...
Autores principales: | Njoku, Kelechi, Barr, Chloe E., Crosbie, Emma J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072738/ https://www.ncbi.nlm.nih.gov/pubmed/35530346 http://dx.doi.org/10.3389/fonc.2022.890908 |
Ejemplares similares
-
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020) -
Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022) -
Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis
por: Njoku, Kelechi, et al.
Publicado: (2022) -
Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis
por: Njoku, Kelechi, et al.
Publicado: (2022) -
Proteomic Biomarkers for the Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2019)